Traws Pharma, Inc. (NASDAQ: TRAW)
$8.0950
+0.0250 ( +0.31% ) 6.5K
Traws Pharma Inc is a biopharmaceutical company focused on developing antivirals for influenza, COVID and other respiratory infections and narazaciclib.
Market Data
Open
$8.0950
Previous close
$8.0700
Volume
6.5K
Market cap
$24.71M
Day range
$8.1350 - $8.7650
52 week range
$4.0600 - $24.7500
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 51 | Apr 16, 2024 |
| 3/a | Insider transactions | 1 | Apr 12, 2024 |
| 3/a | Insider transactions | 1 | Apr 11, 2024 |
| 8-k | 8K-related | 21 | Apr 04, 2024 |
| 3 | Insider transactions | 1 | Apr 03, 2024 |
| 4 | Insider transactions | 1 | Apr 03, 2024 |
| 4 | Insider transactions | 1 | Apr 03, 2024 |
| 3 | Insider transactions | 1 | Apr 03, 2024 |
| 4 | Insider transactions | 1 | Apr 03, 2024 |
| 4 | Insider transactions | 1 | Apr 03, 2024 |